Ad-RTS-hIL-12
Drug timelines are a Plus or Pro feature.
6 regulatory and trial events tracked for Ad-RTS-hIL-12, covering 2025-04-16 to 2025-08-28. Get the full timeline:
Most recent: Clinical Trial Update: Evaluation of Ad-RTS-hIL-12 + Veledimex in Subjects With Recurrent or Progressive Glioblastoma, a Substudy to ATI001-102 [Phase 1]